Triptorelin is a synthetic peptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men.
Tesamorelin is made with growth hormone-releasing factor (GRF). Tesamorelin injection is used to decrease the amount of extra fat in the stomach area in adults with human immunodeficiency virus (HIV) who have lipodystrophy (increased body fat in certain areas of the body). Tesamorelin injection is not used to help with weight loss. Tesamorelin injection is in a class of medications called human growth hormone-releasing factor (GRF) analogs. It works by increasing the production of a certain natural substance that can decrease the amount of body fat.
Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management. In June 2021, the US Food and Drug Administration (FDA) approved semaglutide injection sold for long-term weight management in adults.It can help someone shed 15% of their body weight.
The mitochondrial-derived peptide MOTS-c (mitochondrial open-reading frame of the twelve SrRNA type-c) is a peptide recently discovered by Lee et al., containing 16 amino acid, and it is expressed mainly in the blood plasma, skeletal muscle and heart, both in rodents and human being11,12
Thymalin is the polypeptide drug used for various diseases associated with immune dysfunction, viral and bacterial infections, regeneration normalization, immunodepression, and the depression of hematogenesis after chemical and radiotherapy. The molecular mechanism of the action of thymalin and its components, EW dipeptide (the drug thymogen), the dipeptide KE, and the tripeptide EDP, are analyzed. These short peptides regulate gene expression and the synthesis of heat-shock protein, cytokines, fibrinolysis, gerontogenes, and the differentiation, proliferation, apoptosis of cells. Thymalin and thymogen have practically no side effects and are used for various viral infections.
product origin:
Chinabrand:
Somabiotechshipping port:
China/USAcolor:
Pink Toplead time:
1-2 work days after payment receivedIpamorelin Peptides
Ipamorelin is a penta-peptides hormone. It has similar properties of GHRP-2, it does not have ghrelin's lipogenic properties and does not promote hunger. Ipamorelin acts synergistically when applied during a Releasing Hormone (GHRH) pulse or when it is used along with a GHRH such as Sermorelin or Modified GRF 1-29 (growth releasing factor, aminos 1-29). The synergy comes both due to the suppression of somatostatin and the fact that ipamorelin increases GH release per-somatotrope, while GHRH increases the number of somatotropes releasing GH. On the other hand, Ipamorelin is similar to GHRP-6 in that they both release GH at a very similar strength minus the side effects that of GHRP-6. Both GHRP-2 and GHRP-6 cause a release and an increase in cortisol and prolactin levels, however Ipamorelin only selectively releases GH at any dose. Ipamorelin shares similar function to Hexarelin and compared to other peptides, it is a much more steady form of ghrelin and has longer half-life periods of at least two hours long and causes secondary effect by making neurons to become excited.
Application:
Ipamorelin has demonstrated good safety and tolerability in human clinical studies. Research has shown that Ipamorelin is hormone specific which means that the pituitary hormones such as cortisol are unaffected. In a study, it was found that young female adult rats had increased bone mass due to 12 weeks of treatment with ipamorelin. This peptide compared to other Hormone Releasing Peptides ensures the benefits without having to deal with possible negative side effects.
After an aggressive dosage of ipamorelin, the pituitary gland reacted by reducing the plasma growth hormone levels as opposed to how unchanged they were after comparable dosages of GHRH. This is another positive thing since it proves that ipamorelin will not reduce the production of natural growth hormones overall. This also proves that ipamorelin is a selective growth hormone releaser.
Have A Question? You Can Call Us Or Email Us By Sending A Message Below.
online
info@somabiotech.com
+8617817287544
